{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/RA"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RA\",,,,,undefined,":{"symbol":"RA","market":"US","secType":"STK","nameCN":"Brookfield Real Assets Income Fund Inc.","latestPrice":12.97,"timestamp":1749240000000,"preClose":12.96,"halted":0,"volume":91792,"hourTrading":{"tag":"盘后","latestPrice":12.92,"preClose":12.97,"latestTime":"19:06 EDT","volume":1573,"amount":20333.9765,"timestamp":1749251172226},"delay":0,"floatShares":55254696,"shares":55254696,"eps":-1.61933,"marketStatus":"Market Closed","change":0.01,"latestTime":"06-06 16:00:00 EDT","open":13,"high":13,"low":12.94,"amount":1189555.843168,"amplitude":0.00463,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.61933,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":12.96,"dividendRate":0.109483,"preHourTrading":{"tag":"盘前","latestPrice":13,"preClose":12.96,"latestTime":"08:57 EDT","volume":43,"amount":559.548981,"timestamp":1749214673645},"postHourTrading":{"tag":"盘后","latestPrice":12.92,"preClose":12.97,"latestTime":"19:06 EDT","volume":1573,"amount":20333.9765,"timestamp":1749251172226},"volumeRatio":0.6384652564271236},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RA\",,,,,undefined,":{"symbol":"RA","floatShares":55254696,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.6384652564271236,"shares":55254696,"dividePrice":1.42,"high":13,"amplitude":0.00463,"preClose":12.96,"low":12.94,"week52Low":11.87,"pbRate":"--","week52High":13.77,"institutionHeld":0,"latestPrice":12.97,"eps":-1.61933,"divideRate":0.109483,"volume":91792,"delay":0,"ttmEps":-1.61933,"open":13,"prevYearClose":13.32,"prevWeekClose":12.94,"prevMonthClose":12.94,"prevQuarterClose":13.16,"fiveDayClose":12.94,"twentyDayClose":12.8,"sixtyDayClose":13.26},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/RA\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RA\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2541292098","title":"Crude Oil Falls Over 1%; ISM Services PMI Tumbles In May","url":"https://stock-news.laohu8.com/highlight/detail?id=2541292098","media":"Benzinga","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541292098?lang=en_us&edition=fundamental","pubTime":"2025-06-05 01:16","pubTimestamp":1749057361,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/25/06/45777455/crude-oil-falls-over-1-ism-services-pmi-tumbles-in-may","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANAB","BK4613","TQQQ","ASAN","MNQmain","USJW.SI","BK4579","BK4139","LU0006061336.USD","BK4504","NVIW.SI","RA","BK4155","BK4114","YEXT","QID","BK4585","USAW.SI","NQmain",".IXIC","BK4588","DLTR","SQQQ","CLRB","BK4023","TSYW.SI","QLD","BK4108","PSQ","KWM"],"gpt_icon":1},{"id":"2537960537","title":"CPF Special, MediSave and Retirement Accounts’ interest rate remains at 4% for Q3 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2537960537","media":"businesstimes","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537960537?lang=en_us&edition=fundamental","pubTime":"2025-05-22 03:55","pubTimestamp":1747857327,"startTime":"0","endTime":"0","summary":"Ordinary Account interest rate also remains at 2.5% per annum","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"bustime_highlight","url":"https://www.businesstimes.com.sg/companies-markets/cpf-special-medisave-and-retirement-accounts-interest-rate-remains-4-q3-2025","rn_cache_url":null,"customStyle":"","selectors":"body","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.businesstimes.com.sg/companies-markets/cpf-special-medisave-and-retirement-accounts-interest-rate-remains-4-q3-2025","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"bustime_highlight","symbols":["BK4523","LU0541502299.USD","LU1282648689.USD","LU2265009873.SGD","LU0390134368.USD","LU0287143357.SGD","LU1791710400.SGD","LU0197773673.USD","IE00B0JY6M65.USD","LU0348744763.USD","LU2279701549.SGD","BK4588","LU0708995666.HKD","IE00BYTNYM70.SGD","LU0630378429.USD","LU0197773160.USD","LU0231203729.USD","LU0630378692.HKD","SG9999014005.SGD","LU0431992006.USD","LU1267930656.SGD","LU2177674079.SGD","LU0541501648.USD","LU0918141887.USD","LU0348816934.USD","LU0528227936.USD","LU2226246903.HKD","SG9999014013.SGD","BK4017","RA","IE00B7N09G41.SGD","BK4535","LU1854104046.USD","LU1791710582.SGD","BK4211","HDB","CPF","LU2663582299.SGD","SG9999014021.USD","LU2008162690.USD","LU0868486357.SGD","LU1804176565.USD","LU0536402901.SGD","LU0797268264.HKD","LU0918141705.HKD","BK4566","LU0456842615.SGD","LU1508157978.USD","LU1805238398.USD"],"gpt_icon":0},{"id":"2534251872","title":"Press Release: Metsera Reports First Quarter 2025 Financial Results and Continued Portfolio Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2534251872","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534251872?lang=en_us&edition=fundamental","pubTime":"2025-05-12 19:00","pubTimestamp":1747047600,"startTime":"0","endTime":"0","summary":"MET-097i, a fully biased, monthly, ultra-long acting GLP-1 receptor agonist, is in three ongoing VESPER Phase 2b trials, with data from VESPER-1 expected in mid-2025. MET-233i, a monthly, ultra-long acting amylin analog, is in Phase 1 trials as a monotherapy and co-administered with MET-097i, with five-week monotherapy data expected in Q2 2025. MET-097 (,) an oral formulation of MET-097i, has been accelerated and alternate oral candidate MET-224 is on track, with four-week data for selected lead expected in late 2025. NEW YORK, May 12, 2025  -- Metsera, Inc. , a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, today reported first quarter 2025 financial results and continued portfolio progress.\"The first quarter of 2025 was a period of focused execution and acceleration at Metsera,\" said Whit Bernard, Chief Executive Officer of Metsera. \"We remain on track to deliver on all of our committed clinical milestones fo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTSR","LU2065732104.USD","RA","BK4097","BK4139","PRGS"],"gpt_icon":0},{"id":"2533184327","title":"Press Release: Artiva Biotherapeutics Reports First Quarter 2025 Financial Results, Recent Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2533184327","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533184327?lang=en_us&edition=fundamental","pubTime":"2025-05-08 20:00","pubTimestamp":1746705600,"startTime":"0","endTime":"0","summary":"IND clearance and initiation of global basket trial exploring AlloNK + rituximab in refractory rheumatoid arthritis, Sjgren's disease, idiopathic inflammatory myopathies and systemic sclerosis. First trial to explore an allogeneic cell therapy in refractory rheumatoid arthritis and Sjgren's disease in the U.S.Initial safety, translational data, and lead indication selection to be presented by year-end 2025; initial clinical response data in the lead indication to be presented in 1H2026. Dr. Aslan continued, \"Our longer-term aggressive B-NHL data is maturing into a leading data set, in line with approved auto-CAR-T therapies, providing proof of concept of AlloNK's ability to deplete B-cells deeply and durably. We remain well capitalized to gene","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4077","SLE","ARTV","BK4022","R","RA","BK4232"],"gpt_icon":0}],"pageSize":4,"totalPage":10,"pageCount":1,"totalSize":40,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RA\",params:#limit:5,,,undefined,":[{"date":"2025-06-12","symbol":"RA","amount":0.118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-12","defaultRemindTime":1749735000000,"name":"Brookfield Real Assets Income Fund Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-26","payableDate":"2025-06-12","currency":"USD","dateTimestamp":1749700800000,"payDate":"2025-06-26"},{"date":"2025-05-08","symbol":"RA","amount":0.118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-08","defaultRemindTime":1746711000000,"name":"Brookfield Real Assets Income Fund Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-22","payableDate":"2025-05-08","currency":"USD","dateTimestamp":1746676800000,"payDate":"2025-05-22"},{"date":"2025-04-10","symbol":"RA","amount":0.118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-10","defaultRemindTime":1744291800000,"name":"Brookfield Real Assets Income Fund Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-24","payableDate":"2025-04-10","currency":"USD","dateTimestamp":1744257600000,"payDate":"2025-04-24"},{"date":"2025-03-13","symbol":"RA","amount":0.118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-13","defaultRemindTime":1741872600000,"name":"Brookfield Real Assets Income Fund Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-27","payableDate":"2025-03-13","currency":"USD","dateTimestamp":1741838400000,"payDate":"2025-03-27"},{"date":"2025-02-06","symbol":"RA","amount":0.118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-06","defaultRemindTime":1738852200000,"name":"Brookfield Real Assets Income Fund Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-02-20","payableDate":"2025-02-06","currency":"USD","dateTimestamp":1738818000000,"payDate":"2025-02-20"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RA\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-13","recordDate":"2016-12-15","paymentDate":"2016-12-22","value":0.199,"currency":"USD"},{"executeDate":"2017-03-14","recordDate":"2017-03-16","paymentDate":"2017-03-23","value":0.199,"currency":"USD"},{"executeDate":"2017-04-18","recordDate":"2017-04-20","paymentDate":"2017-04-27","value":0.199,"currency":"USD"},{"executeDate":"2017-05-16","recordDate":"2017-05-18","paymentDate":"2017-05-25","value":0.199,"currency":"USD"},{"executeDate":"2017-06-13","recordDate":"2017-06-15","paymentDate":"2017-06-22","value":0.199,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RA\",market:\"US\",delay:false,,,undefined,":{}}}